Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 61.870 | 62.060 | 0.190 |
Stocks | 38.130 | 74.120 | 35.990 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.613 | 15.318 |
Price to Book | 1.582 | 1.886 |
Price to Sales | 0.975 | 1.311 |
Price to Cash Flow | 5.601 | 8.682 |
Dividend Yield | 2.846 | 3.151 |
5 Years Earnings Growth | 7.015 | 11.514 |
Name | Net % | Category Average |
---|---|---|
Industrials | 35.190 | 20.156 |
Healthcare | 19.850 | 11.407 |
Consumer Cyclical | 12.710 | 13.314 |
Energy | 10.170 | 6.269 |
Technology | 6.730 | 11.691 |
Consumer Defensive | 5.910 | 8.913 |
Financial Services | 5.260 | 13.322 |
Utilities | 3.090 | 5.144 |
Basic Materials | 1.090 | 7.910 |
Number of long holdings: 69
Number of short holdings: 50
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
DSV A/S | - | 4.17 | - | - | |
Stellantis NV | NL00150001Q9 | 4.07 | 20.485 | -1.04% | |
TotalEnergies SE | FR0000120271 | 3.08 | 66.78 | +0.97% | |
Teleperformance | FR0000051807 | 2.91 | 104.35 | +0.05% | |
Airbus Group | NL0000235190 | 2.76 | 157.52 | -0.59% | |
UCB | BE0003739530 | 2.69 | 126.45 | -0.63% | |
COLOPLAST B | - | 2.57 | - | - | |
Novo Nordisk B | DK0062498333 | 2.43 | 908.8 | -0.75% | |
Biomerieux | FR0013280286 | 2.41 | 93.90 | -0.27% | |
Johnson Service | GB0004762810 | 2.40 | 162.80 | -0.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Moneta Multi Caps D | 2.08B | -0.44 | 2.13 | 6.64 | ||
Moneta Multi Caps C | 2.08B | -0.44 | 2.13 | 6.62 | ||
Moneta Micro Entreprises C | 509.69M | 1.36 | 3.82 | 10.33 | ||
Moneta Micro Entreprises D | 509.69M | 1.36 | 3.81 | 10.33 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review